Optimizing Tobacco Dependence Treatment in the Emergency Department
优化急诊科的烟草依赖治疗
基本信息
- 批准号:9300893
- 负责人:
- 金额:$ 75.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAccident and Emergency departmentAcuteAdultAffectAftercareAmericanBehavioralBiochemicalBudgetsCaringCessation of lifeClinicalClinical TrialsClinical Trials DesignCombined Modality TherapyCounselingDevelopmentDirect CostsDiseaseEducationEmergency Department patientEmergency department visitEngineeringEnrollmentEvidence based treatmentFacilities and Administrative CostsFractureFutureGeneral PopulationGoalsHealthHealthy People 2020HospitalsIndividualIndustrializationInjuryInterventionInvestigationLacerationLeadLitigationLow incomeMentally Ill PersonsMethodologyMethodsModelingPamphletsPatientsPharmaceutical PreparationsPhonationPilot ProjectsPoliciesPopulationPrevalencePrimary Health CareProcessQualitative MethodsRandomized Clinical TrialsRegulationReportingResearchResourcesRiskScienceServicesSiteSmokeSmokerSmokingSubstance Use DisorderSurgeonTelephoneTestingTextTimeTobaccoTobacco DependenceTobacco useTreatment EfficacyUnited StatesUnited States National Institutes of HealthVisitWorkWound Healingaddictionarmbasebehavioral pharmacologyclinical efficacycohortcostcost effectivecost effectivenessdesigndrug developmentefficacy testingexperienceexperimental studyhealth economicsinnovationlow socioeconomic statusmedically underserved populationmotivational enhancement therapymulti-component interventionnicotine gumnicotine patchnicotine replacementnovelprogramspublic health relevancequitlinerandomized trialscreening, brief intervention, referral, and treatmentsmoking cessationsymposiumtherapy designtobacco abstinencetrial design
项目摘要
Abstract
Tobacco use remains the leading cause of preventable death in the United States. Smoking is increasingly
a disease of medically underserved populations, including individuals of lower socioeconomic status and those
with behavioral or substance use disorders. Emergency departments (EDs), to which Americans paid 130
million visits in 2013, are excellent clinical settings in which to identify smokers, initiate treatment, and refer for
aftercare. Our previous work has demonstrated the efficacy of a multicomponent intervention in promoting
tobacco abstinence at 3 months. The intervention included a full package of evidence-based treatments,
including initiation of nicotine replacement therapy in the ED, provision of 6 weeks of patches and gum, a brief
motivational interview, active referral to a state smokers' quitline, and a brochure with information on the health
risks of smoking. A subsequent pilot study demonstrated the feasibility and potential efficacy of an intervention
that included short-message-service (SMS) texting to subject cellphones to promote tobacco abstinence. While
efficacious, it is not clear which components of the intervention had the greatest impact, which combinations of
therapy might work best, or which are generalizable to all EDs. In order to design an intervention that is
clinically effective, cost-effective, and practicable, we propose to disentangle the effects of these components
and assemble an intervention that maximizes clinical efficacy, feasibility, and acceptability, given a cost-
effectiveness constraint and findings from qualitative analysis. The methodology we propose using is the
Multiple Optimization Strategy (MOST), a clinical trials design that uses principles adapted from industrial
engineering. We propose an innovative 16-arm full-factorial design in a cohort of 1056 adult smokers in an
urban ED, to test the efficacy of four key components: motivational interviewing, initiation of nicotine
replacement medication, quitline referral, and texting. All subjects will receive a smoking cessation brochure. At
the trial's completion, we will use a novel mixed-methods approach to identify components that were
efficacious within the proposed cost constraint, along with feasibility and acceptability to subjects. We will
assemble components found to be clinically efficacious, cost-effective, and feasible/acceptable into a
multicomponent package for testing in a future randomized clinical trial. Study Aim (1) is to conduct the
factorial experiment; Aim (2) is to analyze trial results to identify the effective components, and Aim (3) is to lay
the groundwork for the subsequent clinical trial testing this multicomponent intervention, versus a control
condition. The multicomponent intervention, once disseminated and implemented, can transform the care of
the tens of millions of smokers who visit U.S. EDs. Our team includes an outstanding array of experts with
deep experience in trial design, including the developer of MOST, emergency department-based investigation,
tobacco dependence treatment, texting, health economics, and qualitative methods.
抽象的
烟草使用仍然是美国可预防死亡的主要原因。吸烟的人越来越多
一种医疗服务不足人群的疾病,包括社会经济地位较低的个人和那些
患有行为或物质使用障碍。急诊室 (ED),美国人向其支付了 130
2013 年就诊人数达 100 万人次,是识别吸烟者、开始治疗和转诊的绝佳临床环境。
善后护理。我们之前的工作已经证明了多成分干预在促进
戒烟3个月。干预措施包括一整套循证治疗,
包括在急诊室开始尼古丁替代疗法、提供 6 周的贴片和口香糖、简短的说明
动机访谈、主动转介州吸烟者戒烟热线以及包含健康信息的小册子
吸烟的风险。随后的试点研究证明了干预措施的可行性和潜在功效
其中包括向受调查者的手机发送短信以促进戒烟。尽管
虽然有效,但尚不清楚干预措施的哪些组成部分产生了最大的影响,以及哪些组合
治疗可能效果最好,或者适用于所有急诊室。为了设计一个干预措施
临床上有效、成本效益高且实用,我们建议理清这些成分的作用
并制定一项干预措施,在考虑到成本的情况下,最大限度地提高临床疗效、可行性和可接受性
有效性约束和定性分析的结果。我们建议使用的方法是
多重优化策略 (MOST),一种临床试验设计,采用工业界改编的原理
工程。我们在 1056 名成年吸烟者的队列中提出了一种创新的 16 臂全因子设计
城市急诊科,测试四个关键组成部分的功效:动机访谈、尼古丁启动
替代药物、戒烟热线转诊和短信。所有受试者都会收到戒烟手册。在
试验完成后,我们将使用一种新颖的混合方法来识别
在拟议的成本限制内有效,以及受试者的可行性和可接受性。我们将
将临床上有效、具有成本效益且可行/可接受的组件组装成
用于在未来随机临床试验中进行测试的多组分包。研究目标 (1) 是进行
析因实验;目标(2)是分析试验结果以确定有效成分,目标(3)是奠定
为后续临床试验测试这种多成分干预措施与对照的基础
健康)状况。多成分干预措施一旦传播和实施,就可以改变对患者的护理
前往美国急诊室就诊的数千万烟民我们的团队包括一批杰出的专家
在试验设计方面拥有丰富的经验,包括 MOST 的开发人员、基于急诊科的调查、
烟草依赖治疗、短信、健康经济学和定性方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven L Bernstein其他文献
Steven L Bernstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven L Bernstein', 18)}}的其他基金
A SMART Approach to Treating Tobacco Use Disorder in Persons Living with HIV
治疗艾滋病毒感染者烟草使用障碍的明智方法
- 批准号:
10247005 - 财政年份:2019
- 资助金额:
$ 75.04万 - 项目类别:
A SMART Approach to Treating Tobacco Use Disorder in Persons Living with HIV
治疗艾滋病毒感染者烟草使用障碍的明智方法
- 批准号:
10478075 - 财政年份:2019
- 资助金额:
$ 75.04万 - 项目类别:
A SMART Approach to Treating Tobacco Use Disorder in Persons Living with HIV
治疗艾滋病毒感染者烟草使用障碍的明智方法
- 批准号:
10696223 - 财政年份:2019
- 资助金额:
$ 75.04万 - 项目类别:
A SMART Approach to Treating Tobacco Use Disorder in Persons Living with HIV
治疗艾滋病毒感染者烟草使用障碍的明智方法
- 批准号:
10020989 - 财政年份:2019
- 资助金额:
$ 75.04万 - 项目类别:
Yale Scholars in Implementation Science (YSIS)
耶鲁大学实施科学学者 (YSIS)
- 批准号:
9372002 - 财政年份:2017
- 资助金额:
$ 75.04万 - 项目类别:
Optimizing Tobacco Dependence Treatment in the Emergency Department
优化急诊科的烟草依赖治疗
- 批准号:
9173355 - 财政年份:2016
- 资助金额:
$ 75.04万 - 项目类别:
A Network Analytic Model of Adherence and Abstinence
依从性和禁欲性的网络分析模型
- 批准号:
8693224 - 财政年份:2014
- 资助金额:
$ 75.04万 - 项目类别:
A Network Analytic Model of Adherence and Abstinence
依从性和禁欲性的网络分析模型
- 批准号:
8847312 - 财政年份:2014
- 资助金额:
$ 75.04万 - 项目类别:
A Network Analytic Model of Adherence and Abstinence
依从性和禁欲性的网络分析模型
- 批准号:
9058014 - 财政年份:2014
- 资助金额:
$ 75.04万 - 项目类别:
Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers
对住院吸烟者实施 HIT 强化烟草治疗
- 批准号:
8337887 - 财政年份:2012
- 资助金额:
$ 75.04万 - 项目类别:
相似海外基金
An Enzyme-Based Antidote for Acute Nicotine Toxicity
一种基于酶的急性尼古丁中毒解毒剂
- 批准号:
10790758 - 财政年份:2023
- 资助金额:
$ 75.04万 - 项目类别:
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial
氯胺酮在急诊科治疗酒精使用障碍:一项双盲、安慰剂对照随机临床试验
- 批准号:
10593244 - 财政年份:2022
- 资助金额:
$ 75.04万 - 项目类别:
Targeting adenosine monophosphate activated protein kinase (AMPK) to reduce cocaine relapse
靶向单磷酸腺苷激活蛋白激酶 (AMPK) 减少可卡因复吸
- 批准号:
10593045 - 财政年份:2022
- 资助金额:
$ 75.04万 - 项目类别:
Targeting adenosine monophosphate activated protein kinase (AMPK) to reduce cocaine relapse
靶向单磷酸腺苷激活蛋白激酶 (AMPK) 减少可卡因复吸
- 批准号:
10303255 - 财政年份:2022
- 资助金额:
$ 75.04万 - 项目类别:
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial
氯胺酮在急诊科治疗酒精使用障碍:一项试点双盲、安慰剂对照随机临床试验
- 批准号:
10703512 - 财政年份:2022
- 资助金额:
$ 75.04万 - 项目类别: